Ming-Qing Du Selected Research

Injections

1/2002

Mucosa-associated lymphoid tissue lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Qing Du Research Topics

Disease

24	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2023 - 01/2002
24	Lymphoma (Lymphomas) 01/2023 - 01/2002
10	Neoplasms (Cancer) 01/2023 - 05/2004
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 09/2006
5	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 01/2016
4	Genetic Translocation (Chromosomal Translocation) 01/2023 - 02/2005
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2013 - 01/2003
3	Bacterial Infections (Bacterial Infection) 02/2012 - 02/2002
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2020 - 09/2009
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 03/2008
2	Necrosis 05/2012 - 09/2006
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2004 - 06/2003
1	Hairy Cell Leukemia 01/2019
1	Glaucoma 05/2013
1	Melanoma (Melanoma, Malignant) 05/2013
1	Uveitis 05/2013
1	Exanthema (Rash) 02/2012
1	Multiple Sclerosis 03/2011
1	Primary Effusion Lymphoma 10/2010
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2010
1	Breast Neoplasms (Breast Cancer) 12/2009
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2009
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2007
1	Infections 11/2007
1	Latent Infection 01/2006
1	Carcinogenesis 05/2005
1	Hyperplasia 11/2004
1	Multiple Myeloma 11/2004
1	Gastritis 08/2003
1	Sialadenitis 08/2003
1	Hashimoto Disease (Thyroiditis, Hashimoto) 08/2003
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2003
1	Lymphadenopathy 11/2002
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 04/2002

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2005
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2006
4	NF-kappa B (NF-kB)IBA 01/2023 - 05/2005
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 05/2002
4	AntigensIBA 01/2019 - 12/2002
4	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2017 - 06/2003
3	Bortezomib (Velcade)FDA Link 01/2023 - 10/2018
3	B-Cell CLL-Lymphoma 10 ProteinIBA 01/2009 - 01/2002
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2011
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 11/2004
2	IgKIBA 01/2019 - 10/2011
2	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 01/2015 - 05/2005
2	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2012 - 04/2012
2	MicroRNAs (MicroRNA)IBA 01/2012 - 12/2009
2	ParaffinIBA 06/2011 - 07/2007
2	Formaldehyde (Formol)FDA Link 06/2011 - 09/2006
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2009 - 01/2006
2	Biomarkers (Surrogate Marker)IBA 03/2008 - 10/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2006 - 04/2002
2	Oxygen (Dioxygen)IBA 08/2003 - 02/2002
1	Rituximab (Mabthera)FDA Link 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	Prednisolone (Predate)FDA LinkGeneric 01/2023
1	BuffersIBA 10/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2019
1	VemurafenibIBA 01/2019
1	Proteasome InhibitorsIBA 10/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	CarbohydratesIBA 01/2017
1	TNF Receptor-Associated Factor 3IBA 01/2017
1	CD40 Ligand (CD40L)IBA 01/2016
1	LigandsIBA 01/2016
1	Mitochondrial DNA (mtDNA)IBA 10/2014
1	16S Ribosomal RNAIBA 03/2014
1	StathminIBA 05/2013
1	Protons (Proton)IBA 05/2013
1	AntibodiesIBA 05/2013
1	Monoclonal AntibodiesIBA 05/2012
1	Oncogene Proteins (Oncogene Protein)IBA 01/2011
1	Arginine (L-Arginine)FDA Link 01/2011
1	Protein Sorting Signals (Signal Peptide)IBA 03/2010
1	NucleotidesIBA 03/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2009
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 11/2007
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2006
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 04/2006
1	UbiquitinIBA 05/2005
1	Ligases (Synthetase)IBA 05/2005
1	Antigen Receptors (Antigen Receptor)IBA 02/2005
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 11/2004
1	Immunoglobulin M (IgM)IBA 11/2004
1	fludarabineIBA 05/2004
1	NucleosidesIBA 01/2004
1	Cladribine FDA LinkGeneric 01/2004
1	RNA (Ribonucleic Acid)IBA 01/2003
1	Immunoglobulin Variable RegionIBA 01/2003

Therapy/Procedure

8	Therapeutics 01/2023 - 05/2002
5	Drug Therapy (Chemotherapy) 01/2019 - 01/2002
3	Radiotherapy 05/2013 - 01/2002
1	Liver Transplantation 01/2023
1	Aftercare (After-Treatment) 02/2012
1	Gastrectomy 04/2003